1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This listing may be outdated. Verify details at the official source before applying.
Find similar grantsNCI SBIR/STTR Strategic Breakthrough Awards is sponsored by National Cancer Institute (NCI). This funding mechanism is designed to accelerate late-stage clinical development of technologies addressing pediatric and rare cancers.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
Going Beyond Funding for Next-Generation Cancer Technologies Boosting the Economy and Driving Innovation Between 1998 and 2018, NCI SBIR/STTR awardees fueled $26. 1 billion in economic output, 100,000+ jobs, and breakthrough cancer technologies.
Latest Opportunities with SBIR NCI SBIR/STTR Commercialization Readiness Pilot (CRP) Program The CRP Program helps small businesses with NCI SBIR/STTR projects bridge the gap between late-stage research and commercialization. The application deadline is September 8, 2026.
NCI SBIR/STTR Investor Initiatives Showcase Companies The NCI SBIR/STTR Investor Initiatives Program is specifically designed to connect funded companies with potential investors and strategic partners. Check out the 2026-2027 showcase companies to learn more.
NCI SBIR/STTR Strategic Breakthrough Awards The NCI SBIR/STTR Phase IIB Strategic Breakthrough Award is a first-of-its-kind funding mechanism designed to accelerate late-stage clinical development of technologies addressing pediatric and rare cancers. The application deadline is September 8, 2026. Biomedical researchers at Illumina are developing next-generation tools to analyze genetic variation and function on a massive scale.
Illumina used NCI SBIR funding to develop their next generation sequencing technology.
According to the current listing, eligibility includes: Small businesses. Confirm the full requirements in the official notice before applying.
The published deadline was September 8, 2026, which has passed. Check the official notice for any future application windows before investing time in a proposal.
NCI SBIR/STTR Strategic Breakthrough Awards is funded by National Cancer Institute (NCI). Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
On May 21, 2026, the National Cancer Institute posted RFA-CA-27-006, RFA-CA-27-007, and RFA-CA-27-008 — the three competitive renewals for the NCI Community Oncology Research Program. Combined FY 2027 commitments reach $147.5 million across roughly 57 awards: $74.5 million for up to 7 Research Bases, $73 million for up to 50 Community and Academic Community Sites. Pre-application webinars run June 16-18 this week. Applications are due August 18, 2026 with six-year project periods. For community hospitals, oncology consortia, and NCI-designated cancer centers, this is the single largest cancer clinical-trials infrastructure decision NCI makes until 2033.
Read articleThe Breast Cancer Research Foundation launched a $100 million venture philanthropy fund at CGI on September 22, 2026, seeded with $23 million and aiming at 20 to 30 companies. Here is what the structure actually means for investigators, for startups in the valley of death, and for every disease foundation now weighing the same move.
Read articlePAR-27-062 creates a three-year, $80,000-salary postdoctoral career award across NCI, NIAID, NIBIB, NIDCR and NINDS — and it carries a hard eligibility window that closes two years after you start your postdoc. Full analysis of the Academic Career Excellence Award, what it replaces, and why the timing rule is the whole competition.
Read article